8-K filing — Nuwellis, Inc. (NUWE)
Filed: 2026-08-26 AccNo: 0001140361-26-034367 Size: 5 MB Item 7.01: Regulation FD Disclosure Item 9.01: Financial Statements and Exhibits
Stocks · News reference
Nuwellis Announces Co-Promotion And Distribution Agreement With Atrility Medical For AtriAmp, Starting With Six-Month Program In Three Territories; Terms Not Disclosed
Reference Details
Connected Markets
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
- Source
- benzinga
- Observed
- Checked
- Cadence
- Captured once, then retained as an archive reference
- Status
- fresh
Keep reading
Related Headlines
Nuwellis Q2 2026 Earnings Call Transcript
Nuwellis (NASDAQ:NUWE) released second-quarter financial results and hosted an earnings call on Thursday. Read the complete transcript below. This content is powered by Benzinga APIs. For comprehensive financial data
Nuwellis Q2 EPS $(26.64) Misses $(0.68) Estimate, Sales $1.969M Miss $2.415M Estimate